For the fourth quarter, which ended Dec. 31, 2014, LifePoint’s revenues grew to $1.3 billion from $952.6 million in the comparable quarter of 2013. Even with the increase in revenue, LifePoint’s net income was down for the quarter due to the negative effect of a $45.5 million impairment charge for the write down of property, equipment, allocated goodwill and certain other assets in connection with the sale of three hospitals in Alabama.
Leif Murphy, executive vice president and CFO of LifePoint, was pleased with the hospital operator’s fourth-quarter financial results and said, “We had another strong quarter in line with our expectations,” in a conference call on Thursday.
For the full fiscal year 2014, LifePoint’s revenues were $4.5 billion, up from $3.7 billion for FY 2013. Net income attributable to the hospital operator for the full year fell to $126.1 million from $128.2 million in FY 2013.
For 2015, LifePoint expects earnings in the range of $3.75 per share to $4.14 per share and revenues of $5.05 billion to $5.15 billion. Analysts expect the hospital operator to see full year earnings of $3.78 per share on revenues of $5.08 billion, according to Nasdaq.
More articles on healthcare finance:
Moody’s: Healthcare sees more upgrades than downgrades in Q4
IASIS Healthcare’s bottom line suffers after exiting Nevada and Florida markets
This not-so-subtle provision of Obama’s budget isn’t sitting well with hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
